The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Abeona Therapeutics Inc shares valued at $51,799 were purchased by Alland Leila on May 16 ’24. At $4.71 per share, Alland Leila acquired 11,000 shares. The insider’s holdings grew to 82,857 shares worth approximately $0.38 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Charles Faith L. purchased 7,550 shares, netting a total of over 24,764 in proceeds. Following the buying of shares at $3.28 each, the insider now holds 78,323 shares.
Before that, Seshadri Vishwas had added 10,000 shares to its account. In a trade valued at $32,000, the Chief Executive Officer bought Abeona Therapeutics Inc shares for $3.20 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $2.47 million.
As published in their initiating research note from Stifel on May 30, 2024, Abeona Therapeutics Inc [ABEO] has been a Buy and the price target has been revised to $21. Analysts at Cantor Fitzgerald upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid November. As of September 18, 2020, B. Riley FBR has initiated its “Buy” rating for ABEO. Earlier on February 10, 2020, SVB Leerink initiated its rating. Their recommendation was “an Outperform” for ABEO stock.
Analyzing ABEO Stock Performance
During the last five days, there has been a surge of approximately 7.24%. Over the course of the year, Abeona Therapeutics Inc shares have dropped approximately -8.38%. Shares of the company reached a 52-week high of $9.01 on 03/06/24 and a 52-week low of $3.05 on 04/25/24. A 50-day SMA is recorded $5.09, while a 200-day SMA reached $5.17. Nevertheless, trading volume fell to 0.56 million shares from 0.42 million shares the previous day.
Support And Resistance Levels for Abeona Therapeutics Inc (ABEO)
According to the 24-hour chart, there is a support level at 4.42, which, if violated, would cause prices to drop to 4.25. In the upper region, resistance lies at 4.79. The next price resistance is at 4.99. RSI (Relative Strength Index) is 51.08 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.18, which suggests the price will decrease in the coming days. Percent R is at 28.40%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
